Genprex, Inc. (GNPX) vs Lakewood-Amedex Biotherapeutics, Inc. (LABT)

A side-by-side comparison of Genprex, Inc. and Lakewood-Amedex Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Genprex, Inc. logo
GNPX
Genprex, Inc.
$1M
$2.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Lakewood-Amedex Biotherapeutics, Inc. logo
LABT
Lakewood-Amedex Biotherapeutics, Inc.
$2M
$0.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GNPX vs LABT

growth of $100 · dividends reinvested · last 1y
GNPX -88.7% (-88.7%/yr)LABT -99.0% (-99.0%/yr)GNPX compounded faster over this window
Log scale — wide-divergence pair
0110100Start $100$11$1
GNPX LABT

GNPX vs LABT: by the numbers

  • •LABT is the larger company ($2M vs $1M market cap).

Metrics side by side

Valuation

MetricGNPXLABT
P/B ratio0.090.35

Profitability

MetricGNPXLABT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-111.51%-169.64%
ROIC-107.08%-163.98%

Growth (annualized)

MetricGNPXLABT
Total return CAGR (5Y)-88.16%N/A

Go deeper

Full GNPX analysisFull LABT analysisInteractive comparison tool

Dig into the metrics

Genprex ROELakewood-Amedex Biotherapeutics ROEGenprex operating marginLakewood-Amedex Biotherapeutics operating marginGenprex revenue growthLakewood-Amedex Biotherapeutics revenue growthGenprex free cash flowLakewood-Amedex Biotherapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.